Dr Victoria Savage is an experienced drug developer and microbiologist with over 15 years’ experience in antimicrobials and antimicrobial resistance (AMR) in both academia and industry. She gained her PhD (2010) and BSc Hons (2006) in Microbiology and Immunology from the University of Leeds. She is the Head of Biology at Infex Therapeutics Ltd, one of Europe’s largest AMR-focused companies, and provides scientific oversight of the company’s portfolio of development programs that covers multiple modalities and indication areas, and leads the Infex biology team of experienced microbiologists. She also sits on the BBSRC’s Pool of Experts to facilitate allocation of funding, Newcastle University Faculty of Medical Sciences Industry Advisory Board, and several AMR-themed consortia aiming to streamline the drug development process for antimicrobials.